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ABSTRACT
Objective: This study investigated the antihyperlipidemic and hepatoprotective effects of the hexane-ethanol fraction of methanol extract of 
Macaranga tanarius (HEM) in rats.
Methods: The hexane-ethanol fraction was screened for toxicity by oral acute toxicity study. The antihyperlipidemic effect of the hexane-ethanol 
fraction and the unsolved of the hexane-ethanol fraction is measured against Wistar rats induced by glucose-fructose diets for 42 days through 
measuring serum cholesterol, triglyceride (TG), high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein cholesterol (LDL-c), and fasting 
blood glucose. The hepatoprotective effect of the hexane-ethanol fraction is determined against Wistar rats with liver damage induced by carbon 
tetrachloride through measuring serum glutamate pyruvate transaminase (SGPT), serum glutamate oxaloacetate transaminase (SGOT), alkaline 
phosphatase (ALP), albumin, lactate dehydrogenase (LDH), and total bilirubin.
Results: There is no toxic effect that was observed on acute toxicity study. The TG, LDL-c, and fasting blood glucose levels were significantly (p<0.05) 
reduced after both of treatment the hexane-ethanol fraction and the unsolved HEM. Administration of the hexane-ethanol fraction 68.6 mg/kgBW 
significantly (p<0.05) prevented elevation of SGPT, SGOT, LDH, ALP, and decreasing of albumin level.
Conclusion: The study showed antihyperlipidemic and hepatoprotective activities of the HEM in animal models.
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INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of 
hepatic steatosis with no evidence of hepatocellular injury in the form 
of ballooning of the hepatocytes. NAFDL is associated with metabolic 
risk factors such as obesity, diabetes mellitus, and dyslipidemia [1]. 
Global prevalence of NAFDL is 25.24%, which was highest in the Middle 
East and South America and the lowest prevalence in Africa. Metabolic 
comorbidities associated with NAFDL included obesity, type 2 diabetes, 
hyperlipidemia, hypertension, and metabolic syndrome. As the global 
epidemic continues to fuel development of metabolic disorders, NAFDL 
will create a massive clinical and economic burden [2].
Carbon tetrachloride (CCL4) is one of the most commonly hepatotoxic 
agents that have been reported to show steatosis, centrilobular 
necrosis, inflammation, fibrosis, and liver cancer in the experimental 
animals [3,4]. Administration of high carbohydrate diet in 
animal models is frequently induced obesity, insulin resistance, 
impaired glucose tolerance, hyperinsulinemia, hypertension, and 
hyperlipidemia [5-10].
Macaranga tanarius is a pioneer species in disturbed rainforest areas. 
It has great potential in scavenging free radical [11,12] and can be a 
vital source of antioxidant phytochemicals [13]. Anti 2,2-diphenyl-
picrylhydrazyl radical-scavenging activity of the isolated compounds of 
M. tanarius also been reported previously [14-16]. These activities are 
effective in treating CCL4 induced toxicity.
The isolated ellagitannin and chebulagic acid of M. tanarius was found 
to inhibit α-glucosidase and intestinal maltase that may benefit diabetes 
treatment [17]. Although the earlier study has demonstrated that the 
hexane-ethanol fraction of methanol extract of M. tanarius (HEM) for 
5 days has not antidiabetic and antihyperlipidemic in rats feed with 
high glucose-fructose (GF) diet [10], a prolonged administration of 
HEM remains to be established.
In this present study, the HEM was interesting to observe for their 
hepatoprotective and antihyperlipidemic anti-inflammatory activities. 
Carbon tetrachloride was chosen as model study for hepatotoxicity and 
administration of high GF to induce hyperlipidemia.
METHODS
Plant material and chemicals
The fresh leaves of M. tanarius were collected from Sleman, Yogyakarta, 
Indonesia and were identified and authenticated using descriptive 
literature. A voucher specimen was deposited in the Laboratory of 
Pharmaceutical Biology, Pharmacy Faculty, Sanata Dharma University, 
Yogyakarta, Indonesia. Sodium carboxymethyl cellulose (CMC) was 
supplied by Brataco Chemika, Indonesia. Glucose, fructose, methanol, 
and carbon tetrachloride as hepatotoxin were from E. Merck (Darmstadt, 
Germany). Olive oil was supplied by Bertolli, Italy. Diagnostic kit for the 
estimation of serum glutamate pyruvate transaminase (SGPT), serum 
glutamate oxaloacetate transaminase (SGOT), alkaline phosphatase 
(ALP), albumin, lactate dehydrogenase (LDH), total bilirubin, glucose, 
cholesterol, high-density lipoprotein cholesterol (HDL-c), low-density 
lipoprotein cholesterol (LDL-c), and triglyceride (TG) kits were 
purchased were from Roche Diagnostics GmbH, Mannheim, Germany. 
All other chemicals were of analytical grade and were purchased from 
E. Merck, Darmstadt, Germany.
Preparation of plant extract
Dried leaves of M. tanarius were extracted with 50% aqueous methanol 
for 24 hrs at room temperature. The crude extract was extracted with 
hexane-ethanol 50:50 for 24 hrs at room temperature. The resulting 
suspension was filtered and was evaporated by vacuum rotary 
evaporator at 50°C to yield a solid residue of soluble HEM (yield 21%) 
and unsoluble of HEM (UHEM) (yield 79%).
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Test animals and housing
Adult male rats of Wistar strain weighing 150-250 g were selected for 
this experiment. The animals were obtained from the Imono Laboratory 
of Pharmacy Faculty of Sanata Dharma University, Indonesia. The 
animals were maintained under standard laboratory condition. They 
were housed in standard cages (five animals per cage) at temperature 
22±2°C and 12:12 hrs light dark cycle. The animals were provided with 
pelleted diet as normal diet or GF-enriched diet and water ad libitum. The 
experimental protocol and procedures used in this study were approved 
with approval number KE/FK/551/EC/2016 by The Medical and Health 
Research Ethics Committee Faculty of Medicine Gadjah Mada University.
Acute oral toxicity study
Acute toxicity study was performed according to the acute toxic 
conventional method. Adult female rats of Wistar strain weighing 
150-250 g were used for acute toxicity study. The animals were kept in 
fasting condition for overnight providing only water, and then, the HEM 
was administered orally at the doses of 34.2, 342, and 3420 mg/kg BW. 
The animals were closely observed for any signs of toxicity during the 
first 3 hrs, and the number of dead animals was recorded at 24 hrs.
Antihyperlipidemic study
Healthy rats were weighed and randomly divided into 4 groups of 
5 animals in each. Group 1 as normal healthy control rats was fed 
normal diet for 52 days. Group 2-4 were fed GF diets for 42 days [9,10]. 
After 42 days, Group 2 were received CMC as negative control, 
whereas Group 3 were administered HEM 34.3 mg/kgBW and Group 4 
were given UHEM 34.3 mg/kgBW. All treatments were fed GF diet 
and continued for 10 days following oral administration. Blood for 
biochemical analysis from all groups was obtained by sinus orbitalis 
after 24 hrs administration. The blood serum was used to measured 
serum cholesterol, TG, HDL-c, LDL-c, and fasting blood glucose. All tests 
were estimated in a Cobas C501 analyzer using commercial kits (Roche 
Diagnostic GmbH, Germany) following standard procedures.
Hepatoprotective study
Healthy rats were weighed and randomly divided into 5 groups of 
5 animals in each. Group 1 were treated with carbon tetrachloride 
(2 ml/kg, i.p.), in a 1:1 solution with olive oil [18,19]. Group 2 received 
olive oil (2 ml/kg, i.p) as negative control. Group 3-5 received HEM 
at doses 34.3, 68.6, and 134.1 mg/kg BW orally once and after 6 hrs, 
respectively, received treated carbon tetrachloride (2 ml/kg, i.p.). Blood 
sample from all groups was obtained by retro-orbital sampling after 
24 hrs application [19-22]. The blood serum was used to measured 
SGPT, SGOT, ALP, albumin, LDH, and total bilirubin. All tests were 
estimated in a Cobas C501 analyzer using commercial kits (Roche 
Diagnostic GmbH, Germany) following standard procedures.
Statistical analyses
The results are expressed as mean±standard deviation. Data were 
analyzed using Kolmogorov-Smirnov test, followed by analysis of 
variance with 95% confidence interval. Scheffe test was used for 
significantly different results using the IBM SPSS 22. Differences were 
regarded as statistically significant with p<0.05.
RESULTS
Acute toxicity study in rats indicated that oral administration of 
HEM produced no toxic effect. No unusual changes in behavior or in 
locomotor activity and no signs of intoxication were observed.
The administration of GF diet exhibited a significant (p<0.05) rise in 
TG, LDL-c, and fasting blood glucose. This was significantly (p<0.05) 
reduced after both of treatment the HEM and the UHEM as shown in 
Table 1.
The effect of HEM on SGPT, SGOT, ALP, albumin, LDH, total bilirubin 
in CCl4 intoxicated rats was summarized in Table 2. The biomarker 
enzyme levels are mainly increased in the hepatic damage by the 
CCl4. SGPT, SGOT, LDH, ALP, and total bilirubin increased significantly 
(p<0.05) and albumin decreased significantly (p<0.05) with CCl4 
treated. Administration of HEM 68.6 mg/kgBW significantly (p<0.05) 
prevented elevation of SGPT, SGOT, LDH, ALP, and decreasing of albumin 
level, thus signifying its hepatoprotective effect.
DISCUSSION
For the acute toxicity study, the results suggest that the HEM is not toxic 
after an acute expose to the dose of 3420 mg/kg.
After 42 days of GF diet, the elevation of TG, LDL-c, and fasting blood 
glucose levels were recorded in this study indicated that GF diet 
caused hyperlipidemia and hyperglycemia in rats. Our previous 
study demonstrated that the HEM for 5 days has not antidiabetic and 
antihyperlipidemic in rats feed with high GF diet [10]. However, in 
this study, concurrent administration 10 days both of HEM markedly 
decreased the release of TG, LDL-c, and fasting blood glucose levels. 
This indicates that the prolonged administration of fraction possesses 
an antihyperlipidemic and antihyperglycemic effect against GF diet. 
Table 1: Effect of HEM on lipid parameters and fasting blood glucose in rats feeds with GF diets
Treatment Cholesterol (mmol/l) Triglyceride (mmol/l) HDL‑c (mmol/l) LDL‑c (mmol/l) Fasting blood 
glucose (mmol/l)
Normal diet 1.70±0.14 0.87±0.10b 0.81±0.02b 0.23±0.01b 3.21±0.16b
GF 1.88±0.15 2.98±0.25a 0.65±0.05a 0.33±0.04a 4.97±0.29a
GF+HEM 34.3 mg/kgBW 1.81±0.19 1.25±0.49b 0.80±0.08b 0.25±0.03b 3.81±0.61b
GF+UHEM 34.3 mg/kgBW 1.92±0.13 2.12±0.14a,b 0.76±0.03b 0.25±0.01b 3.83±0.26a,b
Values are expressed as mean±SD of five animals in each group; ap<0.05 vs normal diet; bp<0.05 vs GF. GF: Glucose-fructose, HDL-c: High-density lipoprotein cholesterol, 
LDL-c: Low-density lipoprotein cholesterol, HEM: Hexane-ethanol fraction of methanol extract of Macaranga tanarius, UHEM: Unsoluble of hexane-ethanol fraction of 
methanol extract of Macaranga tanarius, SD: Standard deviation
Table 2: Effect of HEM on different biochemical parameters in carbon tetrachloride‑induced hepatotoxicity
Treatment SGPT (U/l) SGOT (U/l) Albumin (mg/dl) LDH (U/l) ALP (U/l) Total Bilirubin (mg/dl)
Normal 55.3±4.4b 144.0±6.5b 3.47±0.15b 1021.2±277.0b 177.8±29.0b 0.16±0.01b
Standard CCl4 156.1±16.9a 674.3±12.0a 2.85±0,12a 1848.8±106.85a 244.4±30.6a 0.22±0.05a
HEM 34.3 mg/kgBW 72.2±10.0b 510.4±176.7a 3.39±0.10b 968.4±119.0b 150.8±18.2b 0.22±0.06a
HEM 68.6 mg/kgBW 57.3±10.7b 170.0±39.1b 3.27±0.09a,b 875.0±43.3b 183.0±12.1b 0.21±0.02a
HEM 137.1 mg/kgBW 157.4±20.3a 639.4±35.6a 3.09±0,11a,b 835.8±54.0b 199.6±21.5b 0.24±0.02a
Values are expressed as mean±SD of five animals in each group; ap<0.05 vs normal diet; bp<0.05 vs standard. SGPT: Serum glutamate pyruvate transaminase, 
SGOT: Serum glutamate oxaloacetate transaminase, LDH: Lactate dehydrogenase, ALP: Alkaline phosphatase, HEM: Hexane-ethanol fraction of methanol extract of 
Macaranga tanarius, SD: Standard deviation
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Puteri and Kawabat, 2010, have investigated the α-glucosidase inhibitor 
activity of isolated of M. tanarius [17]. It is reasonable to suppose the 
antihyperlipidemic and antihyperglycemic effect of HEM. Similarly, we 
have shown that the UHEM showed a reduction in TG, LDL-c, and fasting 
blood glucose levels. In contrast, it can be postulated that the UHEM 
contained pharmacologically active compound(s) that interfere with 
the elevation TG, LDL-c, and fasting blood glucose levels.
In this present study, we examined the hepatoprotective effect of 
HEM against liver damage induced by carbon tetrachloride in rats. 
Carbon tetrachloride as common hepatotoxin used in the experimental 
study, induced a significant elevation of blood hydroperoxide and 
malondialdehyde (lipid peroxidation products in liver, moreover, this 
toxicant caused a significant decrease in glutathione content in hepatic 
tissue [23]. Carbon tetrachloride exhibited drastic alterations on liver 
such as extensive fatty change, fatty degeneration [24], and infiltration 
by inflammatory cells [25]. Administration of carbon tetrachloride 
causes severe liver injuries in the present rats. Our results provided 
evidence for the hepatotoxicity effect of carbon tetrachloride (2 ml/kg) 
on the liver functions (Table 2). The SGPT, SGOT, ALP, LDH, albumin, and 
total bilirubin level significantly increased when compared with the 
normal rats [4,26,27]. This injury is indicated of liver cell damage as 
steatosis and leakage of enzymes from cell [18,22,28].
The result of this study shows that the HEM has the potential to protect the 
hepatotoxicity. Since the HEM contains antioxidant compound [11-16], 
it might effective in treating CCl4-induced hepatotoxicity. It results the 
HEM at dose of 68.6 mg/kgBW gave the most potent hepatoprotective 
effect which decreased the elevation of SGPT, SGOT, LDH, ALP, and 
increasing of albumin level. The possible mechanism of action may be 
associated with scavenging of free radicals for CCl4 toxicity.
CONCLUSION
In conclusion, the study showed antihyperlipidemic and 
hepatoprotective activities of HEM in animal modes.
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